4//SEC Filing
Kamal Syed T 4
Accession 0001498068-20-000081
CIK 0001498068other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:33 PM ET
Size
10.7 KB
Accession
0001498068-20-000081
Insider Transaction Report
Form 4
Kamal Syed T
DirectorPresident
Transactions
- Exercise/Conversion
Common Stock
2020-06-01$1.28/sh+208,360$266,701→ 1,192,290 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-01−208,360→ 0 totalExercise: $1.28Exp: 2020-07-09→ Common Stock (208,360 underlying) - Exercise/Conversion
Common Stock
2020-06-01$1.28/sh+208,360$266,701→ 983,930 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-01−208,360→ 0 totalExercise: $1.28Exp: 2020-07-09→ Common Stock (208,360 underlying)
Footnotes (3)
- [F1]Reflects the exercise of options that were otherwise set to expire on July 9, 2020.
- [F2]An option that vested upon the attainment by Centerbridge Capital Partners, L.P. and certain of its affiliates (together, "Centerbridge") of both a 2.5 times return on investment ("MOIC") and a 20% internal rate of return ("IRR").
- [F3]An option that vested upon the attainment by Centerbridge of both a 3.0 times MOIC and a 25% IRR.
Documents
Issuer
American Renal Associates Holdings, Inc.
CIK 0001498068
Entity typeother
Related Parties
1- filerCIK 0001655559
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:33 PM ET
- Size
- 10.7 KB